FDA Inspection 1171177 — Mark S. Denker, MD PA

Mark S. Denker, MD PA — FEI 3004450713

The FDA completed an inspection of Mark S. Denker, MD PA on Jun 6, 2022 in Boca Raton, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jun 6, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boca Raton, FL (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223121 CFR 1271.50(b)(1)Donor screening standards
1223921 CFR 1271.55(b)(2)Listing and interpretation of CD tests performed
1224121 CFR 1271.55(b)(4)Reasons for ineligibility on summary
1224621 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.